Bottom line
HLHIX vs HGHAX: the short answer
HLHIX (Virtus KAR Health Sciences Fund) and HGHAX (The Hartford Healthcare Fund) are both mutual funds.
But HGHAX is far broader, holding 80 positions to 24 for HLHIX, so beyond the top names it adds exposure HLHIX doesn't have.
HLHIX is cheaper at 1.05% vs 1.33% — a difference of $28 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
HLHIX vs HGHAX side by side
| HLHIX | HGHAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Virtus | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.05% | 1.33% |
| Annual cost per $10k | $105 | $133 |
| 10-yr cost on $10k (prospectus) | $1,367 | $2,063 |
| Max front load | 0% | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +7.6% | — |
| 5-yr return (annualized) | +3.8% | — |
| 10-yr return (annualized) | +7.1% | — |
| Best quarter | +16.5% | +20.9% |
| Worst quarter | −11.8% | −15.7% |
| Net assets (fund) | $91.7M | $772.2M |
| Number of holdings | 24 | 80 |
| Portfolio turnover | 13% | 49% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HLHIX | HGHAX | Difference |
|---|---|---|---|
| 2025 | +7.6% | +15.6% | −8.0% |
| 2024 | −2.0% | 0.0% | −2.0% |
| 2023 | +2.8% | +3.8% | −1.0% |
| 2022 | −11.6% | −11.7% | +0.2% |
| 2021 | +25.7% | +10.0% | +15.8% |
| 2020 | +14.1% | +22.6% | −8.5% |
Source: Fund prospectus bar charts
Holdings overlap
11 of HLHIX's top 24 holdings also appear in HGHAX's top 25.
| Holding | HLHIX | HGHAX |
|---|---|---|
| Eli Lilly & Company | 14.84% | 12.03% |
| Abbvie Inc | 5.52% | 4.21% |
| Vertex Pharmaceuticals Inc | 5.32% | 2.64% |
| Merck & Company Inc | 5.06% | 6.00% |
| Unitedhealth Group Inc | 4.65% | 4.74% |
| Intuitive Surgical Inc | 3.89% | 2.88% |
| Amgen Inc | 3.85% | 1.39% |
| Thermo Fisher Scientific Inc | 3.65% | 1.58% |
| Danaher Corp | 3.37% | 2.57% |
| Dexcom Inc | 3.05% | 1.01% |
| Regeneron Pharmaceuticals Inc | 2.90% | 2.02% |
Source: SEC Form N-PORT
HLHIX top 10
- Eli Lilly & Company — 14.84%
- West Pharmaceutical Services Inc — 5.92%
- Abbvie Inc — 5.52%
- Vertex Pharmaceuticals Inc — 5.32%
- Merck & Company Inc — 5.06%
- Unitedhealth Group Inc — 4.65%
- Mckesson Corp — 4.57%
- Mettler-toledo International Inc — 3.99%
- Intuitive Surgical Inc — 3.89%
- Amgen Inc — 3.85%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between HLHIX and HGHAX?
Which is cheaper, HLHIX or HGHAX?
Should I own both HLHIX and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.